FibroGen dividends

FGEN dividends

Ex-dividendAmountYieldPay date

This company doesn't provide dividends.

Pamrevlumab is a fully-human monoclonal antibody that inhibits the activity of connective tissue growth factor (CTGF). CTGF is a common factor in chronic fibrotic and proliferative disorders, characterized by persistent and excessive fibrous tissue which can lead to organ dysfunction and failure, and in cancer, characterized by promotion of tumor growth.

FibroGen

Industry: Biotechnology
Sector: Healthcare
Headquarters: San Francisco, California, United States





Learning section - What Is a Dividend?

A dividend is the distribution of reward from a portion of the company's earnings and is paid to a class of its shareholders. Dividends are decided and managed by the company's board of directors, though they must be approved by the shareholders through their voting rights